Malignant pleural mesothelioma (MPM) is a very aggressive cancer poorly responsive to
current therapies. MPM patients have a very poor prognosis with a median survival of less …

Malignant mesothelioma (MM) is characterized by poor prognosis and short survival.
Extracellular vesicles (EVs) are membrane-bound particles released from cells into various …

Background. Asbestos exposure is associated with increased risk of several diseases,
including malignant mesothelioma (MM). Cell surface glycoprotein mesothelin is …

Simple Summary The continuing increase in mortality from malignant mesothelioma, often a
late effect of asbestos exposure, has gained much public attention. Malignant mesothelioma …

Background. Asbestos exposure is associated with different asbestos-related diseases,
including malignant mesothelioma (MM). MM diagnosis is confirmed with …

Background. Malignant mesothelioma (MM) is a rare, but fatal disease with few treatment
options. The diagnosis and treatment response are challenging in MM. Therefore, the …

Soluble mesothelin-related peptide (SMRP) is a promising biomarker for malignant pleural
mesothelioma (MPM), but several confounding factors can reduce SMRP-based test's …

Recent developments in the field of molecular biology have increased our understanding of
the molecular features of malignant mesothelioma (MM). This knowledge, together with the …

Background: Malignant mesothelioma (MM) is a rare disease with a relatively short overall
survival (OS). Metalloproteinases (MMPs) have a vast biological effect on tumor progression …